Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Connected Drug Delivery Devices Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global connected drug delivery devices market exhibited robust growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 40% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

Connected drug delivery devices are smart wireless electronic systems used to support patient supervision and counseling in home settings. They are equipped with dose reminders, adherence trackers, sensors and monitoring tools to provide instant feedback and education tools for personalized patient care. They are convenient and save costs associated with clinic-based treatment. Consequently, connected drug delivery devices are widely used in the remote monitoring of patients with asthma, diabetes, hepatitis C, hypertension, tuberculosis, multiple sclerosis, clinically isolated syndrome, chronic obstructive pulmonary disease (COPD), and liver and renal transplant recipients.

The rapidly increasing cost of medical management and the rising need to improve patient treatment outcomes are among the main factors catalyzing the demand for connected drug delivery devices. Besides this, a shift in preferences towards home-based care is also stimulating the market growth. Moreover, the rising number of individuals suffering from chronic diseases, along with the increasing emphasis on preventive care, is influencing the market positively. Furthermore, the widespread adoption of connected devices in laboratories and hospitals for maintaining electronic health records (EHR) is driving the market growth. Apart from this, several manufacturers are offering devices that can connect to apps and programs, allow data transfer, enable automated tracking, and maximize patient safety. As they also provide access to real-time patient data, connected drug delivery devices are increasingly being utilized by biopharma companies for determining adherence improvement outcomes to regulators, payers, and patients.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global connected drug delivery devices market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product, end user and technology.

Breakup by Product:

  • Connected Sensors
    • Connected Inhaler Sensors
    • Connectable Injection Sensors
  • Integrated Connected Devices
    • Connected Inhalation Devices
    • Connected Injection Devices
       

Breakup by End User:

  • Hospitals and Healthcare Providers
  • Homecare
     

Breakup by Technology:

  • Bluetooth
  • NFC
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product, End User, Technology, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Adherium Ltd., BioCorp Production, Cohero Health Inc. (AptarGroup Inc.), Elcam Medical ACS. Ltd, Findair Sp. z o. o., Merck KGaA, Phillips Medisize (Molex LLC), Propeller Health (Resmed Inc.), Teva Pharmaceutical Industries Ltd., and West Pharmaceutical Services Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)


Key Questions Answered in This Report:

  • How has the global connected drug delivery devices market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global connected drug delivery devices market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the end user?
  • What is the breakup of the market based on the technology?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global connected drug delivery devices market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Connected Drug Delivery Devices Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1   Connected Sensors
        6.1.1 Market Trends
        6.1.2 Key Segments
           6.1.2.1 Connected Inhaler Sensors
           6.1.2.2 Connectable Injection Sensors
        6.1.3 Market Forecast
    6.2   Integrated Connected Devices
        6.2.1 Market Trends
        6.2.2 Key Segments
           6.2.2.1 Connected Inhalation Devices
           6.2.2.2 Connected Injection Devices
        6.2.3 Market Forecast
7    Market Breakup by End User
    7.1    Hospitals and Healthcare Providers
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Homecare
        7.2.1 Market Trends
        7.2.2 Market Forecast
8    Market Breakup by Technology
    8.1    Bluetooth
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    NFC
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Other Technologies
        8.3.1 Market Trends
        8.3.2 Market Forecast
9    Market Breakup by Region
    9.1   North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2   Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Adherium Limited
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
        14.3.2    BioCorp Production
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
        14.3.3    Cohero Health Inc. (AptarGroup Inc.)
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
        14.3.4    Elcam Medical ACS. Ltd
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
        14.3.5    Findair Sp. z o. o.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
        14.3.6    Merck KGaA
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
           14.3.6.4 SWOT Analysis
        14.3.7    Phillips Medisize (Molex LLC)
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
        14.3.8    Propeller Health (Resmed Inc.)
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Teva Pharmaceutical Industries Ltd.
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    West Pharmaceutical Services Inc.
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis

List of Figures

Figure 1: Global: Connected Drug Delivery Devices Market: Major Drivers and Challenges
Figure 2: Global: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Connected Drug Delivery Devices Market: Breakup by Product (in %), 2020
Figure 5: Global: Connected Drug Delivery Devices Market: Breakup by End User (in %), 2020
Figure 6: Global: Connected Drug Delivery Devices Market: Breakup by Technology (in %), 2020
Figure 7: Global: Connected Drug Delivery Devices Market: Breakup by Region (in %), 2020
Figure 8: Global: Connected Drug Delivery Devices (Connected Sensors) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Connected Drug Delivery Devices (Connected Sensors) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Connected Drug Delivery Devices (Integrated Connected Devices) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Connected Drug Delivery Devices (Hospitals and Healthcare Providers) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Connected Drug Delivery Devices (Homecare) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Connected Drug Delivery Devices (Homecare) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Connected Drug Delivery Devices (Bluetooth) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Connected Drug Delivery Devices (Bluetooth) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Connected Drug Delivery Devices (NFC) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Connected Drug Delivery Devices (NFC) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Connected Drug Delivery Devices (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Connected Drug Delivery Devices (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: North America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: North America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: United States: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: United States: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Canada: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Canada: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Asia-Pacific: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Asia-Pacific: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: China: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: China: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Japan: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Japan: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: India: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: India: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: South Korea: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: South Korea: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Australia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Australia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: Indonesia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: Indonesia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Europe: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Europe: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: Germany: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: Germany: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: France: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: France: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: United Kingdom: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: United Kingdom: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Italy: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Italy: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Spain: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Spain: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Russia: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Russia: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Latin America: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Latin America: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Brazil: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Brazil: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Mexico: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Mexico: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Others: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Others: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Middle East and Africa: Connected Drug Delivery Devices Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Middle East and Africa: Connected Drug Delivery Devices Market: Breakup by Country (in %), 2020
Figure 70: Middle East and Africa: Connected Drug Delivery Devices Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 71: Global: Connected Drug Delivery Devices Industry: SWOT Analysis
Figure 72: Global: Connected Drug Delivery Devices Industry: Value Chain Analysis
Figure 73: Global: Connected Drug Delivery Devices Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Connected Drug Delivery Devices Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Connected Drug Delivery Devices Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 4: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 5: Global: Connected Drug Delivery Devices Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Connected Drug Delivery Devices Market: Competitive Structure
Table 7: Global: Connected Drug Delivery Devices Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links